Drug Testing Locations - Livermore, CO

Drug Testing in Livermore, CO

Livermore, Colorado Statistics

In Livermore, Larimer County, 12% of residents reported illicit drug use over the past year.

Opioid-related hospitalizations in Livermore, Larimer County increased by 15% last year.

Cannabis use in Livermore, Larimer County among teens is at 18%, higher than the state average.

In 2022, over 300 cases of drug-related arrests were reported in Livermore, Larimer County.

Drug overdose fatalities in Livermore, Larimer County rose by 5% compared to the previous year.

Larimer County, including Livermore, saw a 20% rise in methamphetamine usage reports in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Livermore, CO & Drug Testing Policies

Employers in Livermore, CO are increasingly aware of the need for drug-free workplaces. Many have adopted stringent drug testing policies to ensure safety and compliance with state and federal laws.

According to the Occupational Safety and Health Administration (OSHA), these policies often include pre-employment, random, and post-accident testing. Local businesses emphasize support and assistance for employees needing help with substance use issues.

Employers are also encouraged to use guidelines provided by the U.S. Department of Labor to create comprehensive drug-free workplace programs, ensuring both productivity and employee well-being.

Government Efforts with Drug Problems in Livermore, CO

The government of Livermore, CO has implemented several initiatives to curb drug abuse and its impacts. At the local level, programs focusing on prevention and education have been established, targeting youth and vulnerable populations.

Moreover, collaborations with state agencies, like the Colorado Department of Human Services, Office of Behavioral Health, have been strengthened to provide sufficient resources for treatment and rehabilitation. Grant funding and strategic partnerships aim to reduce drug-related issues in the community effectively.

Local Drug Busts & News in Livermore, CO

There have been several notable drug-related events in Livermore, CO. A series of coordinated operations by the Larimer County Sheriff’s Office led to significant drug busts, involving methamphetamine and opioid seizures in 2023.

Events like community forums and awareness campaigns have been organized by local non-profits to raise awareness on drug misuse, partnering with law enforcement to educate the public on prevention strategies.

Recently, the Larimer County Task Force held a press conference highlighting efforts to tackle drug trafficking in the region, stressing the importance of community involvement in reporting suspicious activities.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Livermore, CO. Trusted by employers nationwide for accurate results and exceptional service.

Colorado DOT/Non DOT Physicals

Colorado Vision Tests

Colorado Audiograms

Colorado Respirator Fit Tests

Colorado Lift Tests

Colorado Background Checks

Clinical Testing Services

TB Testing in CO

Diabetes Testing in CO

Infectious Disease Testing in CO

Sickle Cell Anemia Testing in CO

Women/Men's Health Testing in CO

Resources & Citations

Colorado Department of Public Health and Environment - Substance Use Resources

TruCare Health Services

SummitStone Health Partners

The Foundry Treatment Center

Larimer County Behavioral Health Services

Northpoint Colorado

Harmony Foundation

Denver Health Behavioral Health Services

Samudbhava Psychological Services

Westminster Public Schools Health Services

Drug Testing Near Livermore, CO

Drake, CO

Nunn, CO

Timnath, CO

Masonville, CO

Red Feather Lakes, CO

Carr, CO

Fort Collins, CO

Wellington, CO

Laporte, CO

Bellvue, CO

Poudre Park, CO

Buckeye, CO

Frequently Asked Questions

Customer Reviews